Skip to main content
Equibles

Cresset Asset Management, LLC

Position in TECH — BIO-TECHNE Corp

CIK 1761013 Chicago, IL
Back to TECH Full portfolio

Position in TECH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$52,048,420
+$13,418,299 QoQ
Shares Held
736,708
-0.3% QoQ
Ownership
0.470%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#49
of 593 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 69% Shared 0% None 31%

Common Shares in TECH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. TECH ranks #1 (48.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
This page 		736,708 $52,048,420
2 HALO
Halozyme Therapeutics, Inc.
 260,937 $20,423,538
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 7,926 $3,937,081
4 EXEL
Exelixis, Inc.
 70,918 $3,858,648
5 HRMY
Harmony Biosciences Holdings, Inc.
 102,479 $3,731,260
6 TVTX
Travere Therapeutics, Inc.
 35,433 $2,012,948
7 MRNA
Moderna, Inc.
 28,359 $1,985,980
8 PVLA
Palvella Therapeutics, Inc.
 11,629 $1,777,143

All Filings in TECH

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,048,420 736,708
2026-03-31 $38,630,121 739,191
2025-12-31 $40,791,968 693,623
2025-09-30 $35,646,869 640,785
2025-06-30 $32,119,823 624,292
2025-03-31 $35,420,845 604,142
2024-12-31 $13,682,530 189,956
2024-09-30 $18,744,302 234,509
2024-06-30 $16,388,718 228,733
2024-03-31 $14,954,214 212,448
2023-12-31 $7,983,590 103,468
2023-09-30 $2,486,256 36,525
2023-06-30 $2,915,415 35,715
2023-03-31 $1,355,228 18,267
2022-09-30 $1,445,276 5,089
2022-06-30 $1,703,735 4,915
2021-12-31 $236,941 458
2021-09-30 $868,349 1,792
2021-06-30 $384,972 855
2021-03-31 $308,217 807
2020-12-31 $229,588 723